Related to Pharmalink Inks Manufacturing Deal with GP Pharm

• 
• Sequencing Assays
• Roche
• GS GType TET2/CBL/KRAS and the GS GType RUNX1 primer sets are designed for comprehensive genetic variation detection in four key human genes using the 454 GS Junior and GS FLX Systems. The sequence-based assays offer a solution for cancer researche
• 
• Stem Cell Growth
• Life Technologies
• Gibco® KnockOut™ CTS™ SR Growth Factor cocktail and KnockOut CTS ESC/iPSC XenoFree kits enable feeder and feeder-free growth of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). The KnockOut SR GF cocktail is sold
• 
• iPSC Media
• Life Technologies
• Existing feeder-free culture media can contain more than 20 interactive ingredients, many of which, such as bovine serum albumin (BSA) and lipids, are highly uncharacterized and vary significantly from lot to lot. Made in partnership with Cellular
• 
• Tumor Marker Control
• Randox Laboratories
• The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
• 
• Stem Cell Culture Medium
• STEMCELL Technologies
• TeSR™-E8™ is a feeder-free culture medium for human embryonic stem cells (ES cells) and human induced pluripotent stem cells (iPS cells). TeSR-E8 contains only the essential eight components required for maintenance of ES cells and iPS cells. TeSR-
• 
• Stem Cell Culture and Differentiation Substrate
• Primorigen Biosciences
• Vitronectin XF™ is a defined xenobiotic-free cell attachment substrate for stem cell culture and differentiation. As a recombinant fusion protein containing the full-length human vitronectin sequence, Vitronectin XF is expressed in human cells unde
• 
• Hematopoietic Differentiation Medium
• Primorigen Biosciences
• The MesoTotal™ HPC/HSC differentiation system is a new medium and protocol for high efficiency differentiation of human pluripotent stem cells into hematopoietic progenitor cells (CD45/43+ and CD34+) and hematopoietic stem cells (CD45/43+, CD34+, C
• 
• Stem Cell Lines
• Genea Stem Cells
• Embryonic pluripotent cell lines are available including one disease free pluripotent cell line and 24 others with individual mutations that can give rise to several severe diseases such as cancer (breast cancer, Wilm’s tumor, and Von Hippel–Lindau
• 
• Knockout Cell Lines for Cancer Research
• Cellectis bioresearch
• The cells in CanCELL™ cell lines represent comprehensive knockouts of major disease-relevant oncogenes and tumor suppressor genes. CanCELL cell lines are generated using TALEN™ technology and offer opportunities to study signaling pathways and gene
• 
• Transfection Reagent
• Mirus Bio
• TransIT®-BrCa transfection reagent is a dedicated breast cancer cell-line specific reagent that can help researchers achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D. It c
• 
• DNA Reference Standard
• Horizon Discovery
• The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds
• 
• Hematopoietic Colony Imaging System
• STEMCELL Technologies
• STEMvision™ is a bench-top instrument and computer system designed specifically for automated imaging and counting of hematopoietic colonies in the colony-forming unit assay. This system is meant to be used with MethoCult™ media and meniscus-free S